The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A Randomized Phase II Trial Comparing Rhumab VEGF (Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Cell Growth Factor) Plus Carboplatin/Paclitaxel (CP) to CP Alone in Patients with Stage IIIB/IV NSCLC.
 
Jianzhen Lin
No Relationships to Disclose
 
Weiwei Shi
Employment - Origimed
 
Songhui Zhao
Employment - Origimed
 
Jinwei Hu
Employment - Origimed
 
Zheng Hou
Employment - Origimed
 
Ming Yao
Employment - Origimed
 
Gungwei Chrin
Employment - Origimed
Leadership - Origimed
Stock and Other Ownership Interests - Origimed
 
Jie Pan
No Relationships to Disclose
 
Ke Hu
No Relationships to Disclose
 
Lin Zhao
No Relationships to Disclose
 
Milind Javle
No Relationships to Disclose
 
Kai Wang
No Relationships to Disclose
 
Haitao Zhao
No Relationships to Disclose